Oral Anti-diabetes Drugs Market was valued at USD 51.4 Billion in 2022 and is projected to reach USD 78.2 Billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030.
The global oral anti-diabetes drugs market was valued at approximately $45.2 billion in 2022, with an anticipated compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This growth is driven by the increasing prevalence of diabetes worldwide, rising awareness about diabetes management, and advancements in drug development. In particular, the market is experiencing a surge due to the rising adoption of novel oral therapies and combination drugs, which offer enhanced efficacy and patient compliance. The demand for these medications is further supported by the growing aging population and the prevalence of lifestyle-related diabetes.
Opportunities in the oral anti-diabetes drugs market are expanding due to the ongoing research and development of new drug classes and formulations. Emerging markets, particularly in Asia-Pacific and Latin America, present significant growth potential due to their large diabetic populations and improving healthcare infrastructure. The increasing focus on personalized medicine and the development of targeted therapies are expected to open new avenues for market players. Additionally, the rise in healthcare expenditure and supportive government initiatives in these regions are likely to further fuel market expansion, offering lucrative prospects for stakeholders in the coming years.
Get an In-Depth Research Analysis of the Global Oral Anti-diabetes Drugs Market Size And Forecast [2025-2032]
Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy’s Laboratories Ltd
Glenmark Pharmaceuticals Ltd
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Oral Anti-diabetes Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Oral Anti-diabetes Drugs Market
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on Types the Market is categorized into Below types that held the largest Oral Anti-diabetes Drugs market share In 2023.
by Type
Liquid
Capsule
Tablet
by Drug Class
Sulfonylureas
Meglitinides
Biguanides
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Oral Anti-diabetes Drugs Market Research Analysis
1. Introduction of the Global Oral Anti-diabetes Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Oral Anti-diabetes Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Oral Anti-diabetes Drugs Market, By Type
6. Global Oral Anti-diabetes Drugs Market, By Application
7. Global Oral Anti-diabetes Drugs Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Oral Anti-diabetes Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/